Now available CIMERLI™

CIMERLI™ (ranibizumab-eqrn) injection, for intravitreal use, is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with:

- Neovascular (Wet) Age-Related Macular Degeneration (AMD) 

- Macular Edema Following Retinal Vein Occlusion (RVO) 

- Diabetic Macular Edema (DME)

- Diabetic Retinopathy (DR)

- Myopic Choroidal Neovascularization (mCNV)